FDA费用提案缺乏药物再进口的用语
WASHINGTON (Reuters Health) - The US House of Representatives on Tuesday approved a final version of the fiscal 2002 spending bill for the Department of Agriculture and the FDA, after House and Senate negotiators dropped language that would have explicitly allowed individuals to bring back or purchase through the mail prescription drugs from other countries for their own personal use.
The Senate is expected to complete work on the bill before the end of the week.
, http://www.100md.com
The House in July approved the personal reimportation amendment, offered by Rep. Gil Gutknecht, R-MN, by a vote of 324-101. Unlike a year earlier, however, members rejected a broader amendment offered by Rep. Bernie Sanders, I-VT, that would have allowed wholesalers and others to bring back exported drugs at their lower, international prices.
Senators who back drug reimportation, led by Byron Dorgan, D-ND, vowed to continue the fight on the Senate version of the bill. But Dorgan said that the events of September 11 and the need for Congress to act quickly persuaded him not to pursue the change this year.
, http://www.100md.com
Dorgan, however, told Reuters Health that he was eager for the Senate to accept the House language on personal reimportation in conference. That did not happen, however, because House negotiators dropped the language before meeting with Senate conferees. "They came to the conference and said 'this is no longer our position,'" Dorgan said.
A spokesman for Gutknecht said that had the Senate passed even the more limited House language, House negotiators would not have had the option of dropping the language. Said Gutknecht, "I am very disappointed that the House overwhelmingly passed language enabling Americans to save money on safe, FDA-approved drugs and the language is not in the final version of the bill."
, http://www.100md.com
Meanwhile, the FDA in the bill would receive $1.22 billion in funding for the fiscal year that began October 1, up $120 million from fiscal 2001.
Among the increases are an additional $2.5 million for the FDA's Office of Generic Drugs. That increase was pushed by Reps. Sherrod Brown, D-OH, and JoAnn Emerson, R-MO, who are the House sponsors of a broader bill to encourage the quicker approval of generics to control prescription drug prices.
, http://www.100md.com
Also at Brown's urging, the bill includes $3 million for FDA to begin work on a project to combat antibiotic resistance. "We know that antibiotic resistant bacterial infections are being seen more in emergency rooms," said Brown. "We know that overuse and misuse of antibiotics exacerbate antibiotic resistance. But we need to know which drugs are being affected most, and how, when and why antibiotic drugs are being prescribed," he said., 百拇医药
The Senate is expected to complete work on the bill before the end of the week.
, http://www.100md.com
The House in July approved the personal reimportation amendment, offered by Rep. Gil Gutknecht, R-MN, by a vote of 324-101. Unlike a year earlier, however, members rejected a broader amendment offered by Rep. Bernie Sanders, I-VT, that would have allowed wholesalers and others to bring back exported drugs at their lower, international prices.
Senators who back drug reimportation, led by Byron Dorgan, D-ND, vowed to continue the fight on the Senate version of the bill. But Dorgan said that the events of September 11 and the need for Congress to act quickly persuaded him not to pursue the change this year.
, http://www.100md.com
Dorgan, however, told Reuters Health that he was eager for the Senate to accept the House language on personal reimportation in conference. That did not happen, however, because House negotiators dropped the language before meeting with Senate conferees. "They came to the conference and said 'this is no longer our position,'" Dorgan said.
A spokesman for Gutknecht said that had the Senate passed even the more limited House language, House negotiators would not have had the option of dropping the language. Said Gutknecht, "I am very disappointed that the House overwhelmingly passed language enabling Americans to save money on safe, FDA-approved drugs and the language is not in the final version of the bill."
, http://www.100md.com
Meanwhile, the FDA in the bill would receive $1.22 billion in funding for the fiscal year that began October 1, up $120 million from fiscal 2001.
Among the increases are an additional $2.5 million for the FDA's Office of Generic Drugs. That increase was pushed by Reps. Sherrod Brown, D-OH, and JoAnn Emerson, R-MO, who are the House sponsors of a broader bill to encourage the quicker approval of generics to control prescription drug prices.
, http://www.100md.com
Also at Brown's urging, the bill includes $3 million for FDA to begin work on a project to combat antibiotic resistance. "We know that antibiotic resistant bacterial infections are being seen more in emergency rooms," said Brown. "We know that overuse and misuse of antibiotics exacerbate antibiotic resistance. But we need to know which drugs are being affected most, and how, when and why antibiotic drugs are being prescribed," he said., 百拇医药